Tremfya 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F9W99
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,479
Award facts
- Contract value 100% obligated
- $17,478.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,478.62 to AmerisourceBergen Drug Corp for the supply of Tremfya 100 mg/mL syringes. This firm fixed-price, non-set-aside contract was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Tremfya is a prescription biologic medication used to treat plaque psoriasis and psoriatic arthritis. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain. The company's contracts span a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9W99?
SPE2DR26F9W99 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9W99 worth?
The government has obligated $17,479 on SPE2DR26F9W99.
Is contract SPE2DR26F9W99 an order under another contract?
Yes. SPE2DR26F9W99 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9W99 competed?
The extent of competition for SPE2DR26F9W99 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award